DG DISPATCH - AAO: Estrogen Levels Linked To Head And Neck Cancers
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - AAO: Estrogen Levels Linked To Head And Neck Cancers

By Andrew Bowser
Special to DG News

NEW ORLEANS, LA -- September 28, 1999 -- Head and neck cancer is increasingly more common among women, suggesting that differences in the way women metabolize estrogen may be putting them at increased risk for developing the disease.

In a study presented at the annual meeting of the American Academy of Otolaryngology (AAO), Dr. Helen Jung-Sook Koo, of New York Eye and Ear Infirmary, revealed new data indicating that head and neck cancer patients are more likely to express abnormal estrogen metabolism compared with healthy controls. The findings came from a study of urinary levels of estrogen metabolites 16-alpha-hydroxyestrone (16-alpha-OHE1) and 2-hydroxyestrone (2-OHE1).

The researchers found a low ratio of 2-OHE1 (which demonstrates an anti-proliferative effects on estrogen metabolism) to 16-alpha-OHE1 (which demonstrates proliferative effects) in 30 percent of the 50 head and neck cancer patients compared to only 4 percent of 50 age- and sex-matched controls.

Previously, estrogen metabolites have been associated with the pathogenesis of breast and cervical cancer, but this is the first study to demonstrate a link in cancers of sites including the upper aerodigestive tract.

The findings didn’t correlate with sex of the patients in the study group and control group, which contained 40 men and 10 women each. In an interview with Doctor’s Guide, Dr. Koo said the findings suggest 16-alpha-hydroxyestrone and 2-hydroxyestrone may serve as biological markers of increased risk for head and neck cancer.

Should these findings be replicated in a larger study underway now, researchers may study the effects of pharmacologic intervention to alter estrogen metabolic pathways. Similar effects could be exerted by vegetables including broccoli and cauliflower, which contain the phytochemical compound indole-3-carbinol. "It’s a little too early to make specific recommendations, but it’s not unethical to suggest to your patients that they eat vegetables," Dr. Yoo said.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities